Akiho H et al. Role of inflammation in IBS

VISCERAL HYPERSENSITIVITY
Abdominal pain is an essential symptom of IBS and vis-ceral hypersensitivity is the most widely accepted mecha-nism[89]. Visceral sensitivity is regulated at the level of the peripheral (mucosa/submucosa), spinal cord and central nervous system. Non-inflammatory mediators such as stress, glycerol and glutamate, as well as inflammatory mediators have the potential to trigger visceral pain[89]. Inflammatory mediators such as prostaglandin E2 from inflammatory cells, or chemical mediators such as ATP, bradykinin, 5-HT, substance P and calcitonin gene-related peptide, directly activate nerve endings and trigger the release of algesic mediators, histamine, 5-HT, nerve growth factor and prostanoids from other cells and afferent nerves, resulting in an increasing response of pain[89]. Nerve fibers expressing the capsaicin receptor, transient receptor potential vanilloid type-1, were incre-ased in colonic mucosa from IBS patients and may con-tribute to the visceral hypersensitivity and pain in IBS[90]. Recent animal studies showed that 5-HT2B receptor an tagonists[91,92], melatonin[93], corticotrophin-releasing hor-mone receptor 1 antagonists[94] and protease-activated re-ceptor-4[95] inhibited visceral hypersensitivity. These mole-cules are candidates for novel therapies against the visceral hypersensitivity in IBS.

TNF: tumor necrosis factor; IFN: interferon; IL: interleukin; 5-HT: serotonin; MAP: mitogen activated protein; CPI-17: protein kinase C-potentiated phosphatase inhibitor protein-17 kDa; Ref: references.
SECRETOMOTOR DYSREGULATION
Secretomotor neurons
Disordered defecation in IBS is directly related to the physiology of the enteric secretomotor neurons. Secre-tomotor neurons are excitatory motor neurons in the submucosal plexus of the enteric nervous system which innervate and stimulate secretion from the intestinal crypts of Lieberkuhn, Brunner’s glands and goblet cells.Secretomotor neurons have receptors that receive excitatory and inhibitory synaptic inputs from other neurons in the integrative circuitry of the enteric nervous system and from sympathetic postganglionic neurons. They are also influenced by paracrine chemical messages from non-neural cell types in the mucosa and submucosa such as EC cells and immune/inflammatory cells[17,90].
Activation of the excitatory receptors on secretomotor neurons stimulates the neurons to fire and release their transmitters at neuroepithelial junctions in the crypts. Secretomotor neurons express excitatory receptors for acetylcholine, 5-HT and histamine. The overall result of the activation of the excitatory receptors and associated increase in secretomotor neuronal firing is stimulation of the secretion of H2O, electrolytes and mucus from the crypts into the intestinal lumen[90].
Knowledge of the cellular neurobiology of submucosal secretomotor neurons is key to understanding the patho-physiology of secretory diarrhea and constipation. Sup-pression of secretomotor firing by antidiarrheal agents such as opiates is manifested as harder-drier stools. On the contrary, stimulation by chemical mediators such as acetylcholine, 5-HT and histamine is manifested as more
liquid stools[90]. The proinflammatory cytokines IL-1β and TNF-α increased epithelial tight junction permeability in vitro in Caco-2 cells in a dose- and time-dependent man-ner[96,97]. This effect was mediated by an increase in myosin L chain kinase expression and activity. IFNγ is well known to increase tight junction permeability in the T84 cell line accompanied by activation of the PI3-kinase pathway[98]. Green tea[99] and probiotics[100] are candidates for reducing the mucosal hyperpermeability seen in IBS.
EFFECTIVE TREATMENTS
Several emerging clinical trials for IBS are ongoing that target visceral hypersensitivity, motility, neurotransmitters, microbiota and immune systems acting peripherally and/or centrally. Thus far, 5-HT agents have been the most effective for IBS[101,102]. A systematic review showed that the 5-HT3 antagonist alosetron and 5-HT4 agonist tegaserod were more effective than placebos and that serious adverse events were rare, although the Food and Drug Administration announced discontinued marketing of tegaserod due to a potential risk of adverse events, cerebrovascular and cardiovascular ischemic events in 2007[101,102].
One of the excitatory receptors on secretomotor neu rons belongs to the 5-HT3 serotonergic receptor subty-pe[20,103,104]. The observed efficacy of blockade of 5-HT3 receptors by a 5-HT3 antagonist in the treatment of dia rrhea in diarrhea-predominant IBS suggests that over-stimulation of secretomotor neurons by 5-HT is a signifi cant pathophysiological factor in this form of IBS[105,106]. On the contrary, 5-HT4 agonists stimulate GI motility and intestinal secretion and have demonstrated efficacy in improving bowel habits for constipation-predominant IBS[107].
Three 5-HT4 agonists, prucalopride, ATI-7505 and TD-5108, in development are reported to have greater selectivity for 5-HT4 over other receptors and have advan-ced to human trial. 5-HT3 receptor antagonist, ramose-
of the gastrocolic reflex and lessen pain, discomfort, and bowel dysfunction... placebo in the treatment of all three forms of irritable bowel syndrome. ...
Controversies and limitations in irritable bowel syndrome studies_专业资料。维普资讯 http://www.cqvip.com Cieedclora07102)1324 hns i unl0;2(3:4—15 ...
Chapter 10 Psychological Factors and Treatments in Irritable Bowel Syndrome (... there may be no evident psychological correlates of dysfunction and patients...
irritable-bowel-syndrome_英语学习_外语学习_教育... central neural dysfunction, stress, and ...Gastroenteritis may predispose IBS in 25% of ...
The utility of diagnostic tests in irritable bowel syndrome patients: a ... at bedtime Sexual dysfunction, headache, nausea, sedation, insomnia, ...
【国家自然科学基金】_irritable bowel syndrome_期刊发文热词逐年推荐_20140729_英语学习_外语学习_教育专区。2008年 序号 1 2 3 4 5 6 7 8 9 10 11 12 ...
Characterization of auto2 D nomic dysfunction in patients with irritable bowel syndrome by · 文摘· 艺术体操运动员跳跃 、、 提踵 转体动作时间密度统计分析...
in IBD, may lead to pelvic floor dysfunction (PFD) in patients with IBD...Irritable bowel syndrome: a real association or reflection of occult ...
thyroid dysfunction 暂无评价 5页 1财富值 Erectile Dysfunction 暂无评价 356...Anesthesia in Irritable Bowel Syndrome (IBS) Patients Lene Vase, Donald D....
D efecatory dysfunction is common in women, but is often underrecognized and...cIBS = constipation-predominant irritable bowel syndrome. multiple classes of ...
热门文档